Clinical Trials Directory

Trials / Unknown

UnknownNCT04374916

Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Threatened preterm labor (TPL) is defined by cervical changes and regular and painful uterine contractions occurring between 24 and 36 + 6 weeks of gestation that may or may not lead to premature labor and delivery. There is no reliable way to predict preterm delivery. The study's hypothesis is that the Premaquick® test can improve the prediction of preterm delivery. The investigators also want to compare this test with the Partosure® (Placental alpha microglobulin-1) test.

Conditions

Interventions

TypeNameDescription
DEVICEPremaquick®Vaginal secretions are collected prior to any vaginal or endovaginal ultrasound examination to avoid false positives, with the nylon swab provided with the test (placed in the posterior fornix of the vagina for 10 seconds).Then the samples are tested with the Premaquick test. Results are obtained in 10 minutes.
DEVICEPARTOSURE®An immunochromatographic test wich determines the qualitative in vitro detection of placental alpha microglobulin-1 (PAMG-1) in cervico-vaginal secretions.

Timeline

Start date
2020-08-11
Primary completion
2022-08-25
Completion
2022-08-25
First posted
2020-05-05
Last updated
2021-10-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04374916. Inclusion in this directory is not an endorsement.